Related references
Note: Only part of the references are listed.The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database
Maiko Okano et al.
JOURNAL OF HUMAN GENETICS (2021)
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
Reiko Yoshida
BREAST CANCER (2021)
Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
Maria Isabel Achatz et al.
JCO GLOBAL ONCOLOGY (2020)
Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines
Cynthia L. Neben et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil
Nilson Moreira Cipriano et al.
BREAST CANCER (2019)
Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark
Shan Yang et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
The ACMG/AMP reputable source criteria for the interpretation of sequence variants
Leslie G. Biesecker et al.
GENETICS IN MEDICINE (2018)
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
Edenir Inez Palmero et al.
SCIENTIFIC REPORTS (2018)
Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countries
Natalia Teixeira et al.
MATURITAS (2017)
BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
Baarbara Alemar et al.
PLOS ONE (2017)
Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers
Eli Marie Grindedal et al.
BMC CANCER (2017)
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
Lisa R. Susswein et al.
GENETICS IN MEDICINE (2016)
BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
Ingrid Petroni Ewald et al.
GENETICS AND MOLECULAR BIOLOGY (2016)
Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations
Barbara Alemar et al.
CANCER GENETICS (2016)
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
Timothy R. Rebbeck et al.
BREAST CANCER RESEARCH (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations
Anna P. Sokolenko et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers
Karen H. Lu et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients
Jae Myoung Noh et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Multiple jejunal cancers resulting from combination of germline APC and MLH1 mutations
Noralane M. Lindor et al.
FAMILIAL CANCER (2012)
Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil
Crisle Vignol Dillenburg et al.
GENETICS AND MOLECULAR BIOLOGY (2012)
Mutation Analysis of BRCA1, BRCA2, PALB2 and BRD7 in a Hospital-Based Series of German Patients with Triple-Negative Breast Cancer
Franziska Pern et al.
PLOS ONE (2012)
Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population
O. Lavie et al.
ANNALS OF ONCOLOGY (2011)
Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics
Monica Zuradelli et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations -: art. no. e20
B Leegte et al.
JOURNAL OF MEDICAL GENETICS (2005)
Highly penetrant hereditary cancer syndromes
R Nagy et al.
ONCOGENE (2004)
The BOADICEA model of genetic susceptibility to breast and ovarian cancer
AC Antoniou et al.
BRITISH JOURNAL OF CANCER (2004)
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2004)
Share Paper
